SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-21-005311
Filing Date
2021-05-13
Accepted
2021-05-13 16:36:57
Documents
52
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 h51021110q.htm 10-Q 674507
2 EXHIBIT 10.3 ex10_3.htm EX-10.3 318777
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 7775
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 7964
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 4302
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 4636
7 GRAPHIC chart.jpg GRAPHIC 95851
  Complete submission text file 0001214659-21-005311.txt   3068937

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE hgen-20210331.xml EX-101.INS 256946
9 XBRL SCHEMA FILE hgen-20210331.xsd EX-101.SCH 42869
10 XBRL CALCULATION FILE hgen-20210331_cal.xml EX-101.CAL 38228
11 XBRL DEFINITION FILE hgen-20210331_def.xml EX-101.DEF 114529
12 XBRL LABEL FILE hgen-20210331_lab.xml EX-101.LAB 272927
13 XBRL PRESENTATION FILE hgen-20210331_pre.xml EX-101.PRE 177899
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 21920218
SIC: 2834 Pharmaceutical Preparations